Injectafer denied for failing step therapy by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for injectafer are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Applies Step Therapy to Injectafer

Step therapy — sometimes called "fail-first" — requires that a patient try and document inadequate response to one or more lower-cost alternatives before UnitedHealthcare will cover a preferred or more expensive agent like Injectafer (ferric carboxymaltose). For IV iron products, UHC's step-therapy protocol may require documented trials of oral iron therapy or a lower-cost IV iron formulation. A step-therapy denial means UHC's reviewer concluded the required prior steps were either not attempted or not sufficiently documented.

## Why This Denial Is Appealable

Step-therapy requirements cannot be applied rigidly when there is a documented clinical reason why the required prior step is contraindicated or clinically inappropriate for the individual patient. Most states have enacted step-therapy reform laws that require insurers to honor exemptions when a clinician certifies that the step-therapy alternative is not medically appropriate. Even in states without specific reform statutes, the ACA's appeal framework requires individualized clinical review. If you have already tried required alternatives, the issue may be documentation — a curable problem on appeal.

## Your Federal Appeal Rights

• Step-therapy exemption request: This is often faster than a full appeal. Your prescriber submits an exemption certification documenting why prior-step alternatives are clinically inappropriate.
• Internal appeal (ACA §2719): If the exemption is denied or unavailable, file a formal internal appeal.
• External review: Independent reviewers assess whether the step-therapy requirement was applied appropriately given your individual clinical circumstances.
• ERISA §503: Employer self-funded plans must provide the complete administrative record on request.
• State law: Many states impose additional protections requiring the insurer to grant an exemption within a set timeframe when a clinician certifies medical necessity for the non-step drug.
• Timeline: File external review within four months of the final internal adverse determination.

## Documentation to Gather

1. Prior treatment history: For each required step-therapy alternative — oral iron products, or other IV iron agents — document the name, dates of use, dose adjustments, and documented outcomes (inadequate response, adverse effects, intolerance). 2. Clinical reason for bypassing a step: If a step was not taken because it was clinically contraindicated (e.g., malabsorption syndrome, inflammatory bowel disease, intolerance), document that reason explicitly in the chart and in the prescriber letter. 3. Diagnosis and severity records: Lab trends, specialist notes, and any procedural records establishing the underlying condition causing iron deficiency. 4. Prescriber exemption letter: A detailed letter stating which step-therapy requirements have been met or why they cannot be met, citing the applicable clinical guideline organization. 5. UHC's step-therapy criteria and state exemption law: Obtain UHC's published step-therapy policy and review your state's step-therapy reform statute for additional protections.

## Criteria-Mapping Structure

Your appeal package needs two components: (1) a step-fulfillment table showing each required prior step in the left column and the chart evidence of attempted use or clinical contraindication in the right column; and (2) a separate section addressing why Injectafer is the appropriate agent at this stage. If prior steps were attempted but documentation is thin, ask your prescriber to add a contemporaneous chart addendum memorializing the clinical history before filing the appeal.